In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the most influence on the declines.
Dr Fleseriu discusses reproductive assistance options that can be pursued in patients with hypopituitarism who want to become pregnant, how endocrinologists can best navigate prescribing appropriate levels of pituitary hormone replacement therapy among pregnant patients, and more.
Caroline Trapp, DNP, ANP-BC, CDCES, on Achieving Remission of Type 2 Diabetes Through Lifestyle Medicine
In this podcast, Caroline Trapp, DNP, ANP-BC, CDCES, talks about ways to achieve partial and full remission of type 2 diabetes and how certified diabetes care and education specialists can identify the type and intensity of lifestyle modifications required for significant metabolic improvements and remission.
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about the effect of smoking status on the association between diabetes and cardiovascular mortality, including how social factors impact tobacco use, how smoking cessation can decrease mortality from diabetes, and how diabetes can interact with other risk factors to affect cardiovascular health. He presented a poster abstract on this topic at the ADCES21 annual conference.
In this podcast, Akira Sekikawa, MD, PhD, talks about his research on the association of atherosclerosis and bone mineral density in an international cohort of middle-aged men.
Dr Lentle discusses his research that addresses the lack of a precise definition of osteoporotic vertebral fractures, methods for identifying these fractures and distinguishing them from nonfracture lesions, and potential strategies for simplifying the terminology associated with these conditions.
In this podcast, Ahmed Elhakeem, MPH, PhD, talks about how time spent in various physical activity levels throughout adolescence impacts peak bone strength and osteoporosis risk later in life.
In this podcast, Sameer Naranje, MD from the University of Alabama at Birmingham, discusses which groups are most at risk for osteoporosis, best practices for mitigating fracture risk in these populations, and management strategies for patients who experience fractures.
Dr Turchin discusses the findings of his recent study, which identified predictors and consequences of declining insulin therapy among patients with type 2 diabetes. He also explains how endocrinologists and related clinicians treating diabetes can address these areas and reach these patients.
Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new guideline.